Novonesis and Biotalys Collaborate to Produce and Market Biofungicide EVOCA NG

Novonesis and Biotalys, two prominent companies in the agricultural industry, have announced a long-term collaboration to develop and commercialize the biofungicide EVOCA NG. This partnership combines Biotalys' expertise in protein-based agricultural biocontrol products with Novonesis' position as a global leader in the biotechnology solutions sector. The joint effort aims to revolutionize crop protection and provide effective solutions against devastating fungal diseases.

Novonesis and Biotalys have joined forces to revolutionize the agricultural sector with their collaborative efforts in producing and marketing the biofungicide EVOCA NG. Biotalys, an agricultural technology company, specializes in developing protein-based biocontrol products, while Novonesis is a leading global player in the biotechnology solutions industry.

The partnership between these two companies involves a long-term commitment to the production, global supply, and targeted commercialization of the biofungicide EVOCA NG. This innovative product offers a new mechanism of action and has demonstrated its efficacy in extensive field trials against fungal diseases such as gray mold and powdery mildew.

Under this collaboration, Novonesis will invest in expanding its production capacity to support the global commercialization of EVOCA NG. Biotalys has granted Novonesis exclusive distribution rights for EVOCA NG in selected regions outside of the United States. In return, Biotalys will receive royalty fees from Novonesis based on net sales of EVOCA NG in all covered regions.

The development of EVOCA NG involves an optimized production process and formulation technology, making it a highly competitive product in the market. The active ingredient of EVOCA NG is derived from proteins, providing exceptional efficacy in protecting fruits and vegetables from fungal diseases. This biofungicide has gained recognition from the Fungicide Resistance Action Committee (FRAC) and received its unique code.

The collaboration between Novonesis and Biotalys extends beyond EVOCA NG. The companies will explore additional opportunities, including the potential combination of Biotalys' promising AGROBODY™ technology with Novonesis' biocontrol solutions. These joint efforts aim to provide farmers with cutting-edge plant protection products that contribute to sustainable and efficient crop production.

The field of biological crop protection is a rapidly growing segment within the crop protection market, projected to exceed a value of $15 billion by 2029. Biofungicides, such as EVOCA NG, are expected to capture a significant share of this market, reaching a value close to $5 billion. The collaboration between Novonesis and Biotalys positions them at the forefront of this industry, poised to meet the increasing demand for sustainable and effective agricultural solutions.

Novonesis and Biotalys have embarked on a strategic collaboration to produce and market the biofungicide EVOCA NG. By leveraging their respective strengths in biotechnology and protein-based biocontrol products, these companies aim to revolutionize crop protection and contribute to sustainable agriculture. Through this partnership, they are poised to provide farmers with innovative solutions against fungal diseases, ensuring the health and productivity of crops worldwide.